Daily Newsletter

01 September 2023

Daily Newsletter

01 September 2023

Work underway on West Cumberland Hospital redevelopment phase two

The new building will feature stroke rehabilitation, specialist palliative care, paediatrics and elderly care wards.

Satarupa Bhowmik August 31 2023

Work is in progress on the £40m phase two redevelopment of West Cumberland Hospital in Whitehaven, Cumbria, England, with opening targeted by next summer.

As part of the second phase, up to 40% of the original hospital building will be replaced. The new building will feature stroke rehabilitation, specialist palliative care, paediatrics and elderly care wards.

A  central outdoor courtyard space will allow natural light penetration in the wards.

Specialist stroke physiotherapist Paul Satterley said: “There is much more space and the whole area gives us much better opportunities for more effective rehabilitation. The therapy room will house various equipment like parallel bars and the outdoor courtyard will really help us to more effectively train people to walk again.” 

The elderly care unit will move to the new building, with plans for creation of single rooms and four-bedded bays.

First brick on the new extension was placed in May last year, while phase one of the project was completed in 2015. 

Matron for the ward Christine Musgrave, said: “The new ward has been specifically designed with patients at the heart and staff have been involved in that process right from the start. We know some patients want the privacy and space of a single ensuite bedroom.

“However, we also know from talking to patients, that some crave social interaction and the company of others so we will also have some 4-bedded bays. We have also worked hard to make sure the new ward will be dementia-friendly. Colour and pattern play a huge role in helping dementia patients so we will be using that to full effect.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close